Orange Book product · Generic (ANDA)
ILOSONE
ERYTHROMYCIN ESTOLATE
At a glance
Approved Prior to Jan 1, 1982
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
No patent or exclusivity dates are listed for this product.
Pharmaceutical detail
Active ingredient
ERYTHROMYCIN ESTOLATE
Strength
EQ 125MG BASE
Dosage form
TABLET, CHEWABLE
Route
ORAL
TE code
Not listed
Application
ANDA 061895
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of ERYTHROMYCIN ESTOLATE
- —ILOSONEBrand (NDA)
NDA 050010 · LILLY
- 1990ERYTHROMYCIN ESTOLATEGeneric (ANDA)
ANDA 062169 · COSETTE
- 1982ERYTHROMYCIN ESTOLATEGeneric (ANDA)
ANDA 062362 · LIFE LABS
- 1982ERYTHROMYCIN ESTOLATEGeneric (ANDA)
ANDA 062409 · ALPHARMA US PHARMS
- 1982ERYTHROMYCIN ESTOLATEGeneric (ANDA)
ANDA 062353 · ALPHARMA US PHARMS
- —ERYTHROMYCIN ESTOLATEGeneric (ANDA)
ANDA 062162 · BARR
- —ERYTHROMYCIN ESTOLATEGeneric (ANDA)
ANDA 062237 · IVAX SUB TEVA PHARMS
- —ERYTHROMYCIN ESTOLATEGeneric (ANDA)
ANDA 062087 · WATSON LABS
- —ILOSONEGeneric (ANDA)
ANDA 061897 · LILLY
- —ILOSONEGeneric (ANDA)
ANDA 061893 · DISTA
- —ILOSONEGeneric (ANDA)
ANDA 061894 · LILLY
- —ILOSONEGeneric (ANDA)
ANDA 061896 · LILLY
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
